These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17154227)

  • 1. Fetal anomaly scan potentially will replace routine AFAFP assays for the detection of neural tube defects.
    Kooper AJ; de Bruijn D; van Ravenwaaij-Arts CM; Faas BH; Creemers JW; Thomas CM; Smits AP
    Prenat Diagn; 2007 Jan; 27(1):29-33. PubMed ID: 17154227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
    Henriques CU; Damm P; Tabor A; Pedersen JF; Mølsted-Pedersen L
    Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects.
    Lancet; 1979 Sep; 2(8144):651-62. PubMed ID: 90757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sonography, a complementary examination to alpha-fetoprotein testing for fetal neural tube defects.
    Hashimoto BE; Mahony BS; Filly RA; Golbus MS; Anderson RL; Callen PW
    J Ultrasound Med; 1985 Jun; 4(6):307-10. PubMed ID: 2409295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal diagnosis, fetal surgery, recurrence risk and differential diagnosis of neural tube defects.
    Chen CP
    Taiwan J Obstet Gynecol; 2008 Sep; 47(3):283-90. PubMed ID: 18935990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage II ultrasound examination for the diagnosis of fetal abnormalities with an elevated amniotic fluid alpha-fetoprotein concentration.
    Hobbins JC; Venus I; Tortora M; Mayden K; Mahoney MJ
    Am J Obstet Gynecol; 1982 Apr; 142(8):1026-9. PubMed ID: 6176125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine amniotic fluid alphafetoprotein assay: experience with 40,000 pregnancies.
    Crandall BF; Matsumoto M
    Am J Med Genet; 1986 May; 24(1):143-9. PubMed ID: 2422932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increased AFP in maternal serum as an indication for invasive diagnosis].
    Gremm B; Sohn C; Beldermann F; Bastert G
    Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
    Miller RC; Wolf EJ; Gould M; Macri CJ; Charnas LR
    Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
    Widlund KF; Gottvall T
    Acta Obstet Gynecol Scand; 2007; 86(2):167-71. PubMed ID: 17364279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of amniotic fluid alpha-fetoprotein: sonographic evaluation.
    Robbin M; Filly RA; Fell S; Goldstein RB; Callen PW; Goldberg JD; Golbus MS
    Radiology; 1993 Jul; 188(1):165-9. PubMed ID: 7685529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine measurement of amniotic fluid alpha-fetoprotein and acetylcholinesterase: the need for a reevaluation.
    Flick A; Krakow D; Martirosian A; Silverman N; Platt LD
    Am J Obstet Gynecol; 2014 Aug; 211(2):139.e1-6. PubMed ID: 24530818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum alpha-fetoprotein screening: promise not yet fulfilled.
    Nadler HL; Simpson JL
    Am J Obstet Gynecol; 1979 Sep; 135(1):1-2. PubMed ID: 89812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of AFP in amniotic fluid: comparison of three automated techniques].
    Leguy MC; Tavares Sdos R; Tsatsaris V; Lewin F; Clauser E; Guibourdenche J
    Ann Biol Clin (Paris); 2011; 69(4):441-6. PubMed ID: 21896409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of 12 years' combined maternal serum alpha-fetoprotein screening and ultrasound fetal monitoring for prenatal detection of fetal malformations in Havana City, Cuba.
    Rodríguez L; Sánchez R; Hernández J; Carrillo L; Oliva J; Heredero L
    Prenat Diagn; 1997 Apr; 17(4):301-4. PubMed ID: 9160380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic use of meternal serum alpha-fetoprotein levels.
    Cowchock FS; Jackson LG
    Obstet Gynecol; 1976 Jan; 47(1):63-8. PubMed ID: 54892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks for fetal abnormalities after very and moderately elevated AF-AFPs.
    Crandall BF; Chua C
    Prenat Diagn; 1997 Sep; 17(9):837-41. PubMed ID: 9316128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal detection of neural tube defects. VI. Experience with 20,000 pregnancies.
    Milunsky A
    JAMA; 1980 Dec; 244(24):2731-5. PubMed ID: 6160265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The usefulness of the level of alpha-fetoprotein (AFP) and electrophoresis of amniotic acetylcholinesterase for the detection of selected congenital malformations].
    Lemonnier MC; Julian C; Aymé S; Philip N; Voeckel MA; Gamerre M; Mattéi JF
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(3):280-4. PubMed ID: 1693158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal plasma alpha-fetoprotein screening for fetal neural tube defects.
    Brock DJ; Scrimgeour JB; Steven J; Barron L; Watt M
    Br J Obstet Gynaecol; 1978 Aug; 85(8):575-81. PubMed ID: 80224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.